AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1620773 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug therapy
Number of subjects: 37
Study 6375760 — intervention group
Group type: EXPERIMENTAL
Intervention: Daunorubicin (45 mg/m2 IV on days 1, 2, 3)
Number of subjects: 177
Study 6375760 — intervention group
Group type: COMPARATOR
Intervention: Vincristine, prednisone, and L‐asparaginase alone
Number of subjects: 177
Study 6375760 — intervention group
Group type: EXPERIMENTAL
Intervention: Daunorubicin (in subsequent nonrandomized treatment)
Number of subjects: 177
Study 6375760 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance therapy (6-mercaptopurine and methotrexate with periodic reinforcement with vincristine and prednisone)
Number of subjects: 177
Study 6375760 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete response
Number of subjects: 177
Study 30755061 — intervention group
Group type: EXPERIMENTAL
Intervention: Evolocumab (PCSK9 inhibitor)
Number of subjects: 895
Study 28004321 — intervention group
Group type: COMPARATOR
Intervention: Minilaparotomy cholecystectomy (MC)
Number of subjects: 109
Study 28004321 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic cholecystectomy (LC)
Number of subjects: 109
Study 28004321 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined MC and LC
Number of subjects: 109
Study 26003770 — intervention group
Group type: EXPERIMENTAL
Intervention: External cold and vibration via Buzzy
Number of subjects: 0
Study 26003770 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 0
Study 23178050 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise-based cardiac rehabilitation
Number of subjects: 26957
Study 23178050 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant medication
Number of subjects: 26957
Study 23178050 — intervention group
Group type: COMPARATOR
Intervention: Nondepressed cohort
Number of subjects: 26957
Study 22047557 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivacaftor (150 mg every 12 hours)
Number of subjects: 167
Study 22047557 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 167
Study 20092592 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine 0.05%
Number of subjects: 44
Study 20092592 — intervention group
Group type: COMPARATOR
Intervention: Artificial tears
Number of subjects: 44
Study 17061966 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-managed group (n = 68)
Number of subjects: 141
Study 17061966 — intervention group
Group type: COMPARATOR
Intervention: Physician-managed group (n = 69)
Number of subjects: 141
Study 17061966 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-managed group
Number of subjects: 141
Study 17061966 — intervention group
Group type: COMPARATOR
Intervention: Physician-managed group
Number of subjects: 141
Study 15014543 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm-up exercise prior to SAP
Number of subjects: 20
Study 15014543 — intervention group
Group type: COMPARATOR
Intervention: Resting prior to exposures
Number of subjects: 20
Study 12170942 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemether
Number of subjects: 52
Study 12170942 — intervention group
Group type: COMPARATOR
Intervention: Quinine
Number of subjects: 52
Study 9781946 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative chemotherapy
Number of subjects: 465
Study 9781946 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged chemotherapy
Number of subjects: 465
Study 7529924 — intervention group
Group type: EXPERIMENTAL
Intervention: Iloprost treatment (10 micrograms/ml for the first 3 days, then 40 micrograms/ml for the remaining period, applied daily for 8 weeks)
Number of subjects: 99
Study 7529924 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 99
Study 3296624 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxiracetam (2.4 mg per day)
Number of subjects: 106
Study 3296624 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study 29323628 — intervention group
Group type: EXPERIMENTAL
Intervention: CONTECI telehealth program (Intervention Arm)
Number of subjects: 150
Study 29323628 — intervention group
Group type: COMPARATOR
Intervention: In-person patient visits (Control Arm)
Number of subjects: 150
Study 28302573 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-min low-to-moderate intensity stair walking
Number of subjects: 18
Study 28302573 — intervention group
Group type: COMPARATOR
Intervention: 50mg caffeine capsule
Number of subjects: 18
Study 28302573 — intervention group
Group type: COMPARATOR
Intervention: Flour (placebo) capsule
Number of subjects: 18
Study 26252477 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic Training (AT)
Number of subjects: 196
Study 26252477 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 196
Study 26252477 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Aerobic and Resistance Training (ATRT)
Number of subjects: 196
Study 26252477 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 196
Study 23819816 — intervention group
Group type: EXPERIMENTAL
Intervention: Values-focused intervention with a third day of training and 12 months of coaching
Number of subjects: 200
Study 23819816 — intervention group
Group type: COMPARATOR
Intervention: Implementation training (control group)
Number of subjects: 200
Study 22240886 — intervention group
Group type: EXPERIMENTAL
Intervention: Topically applied calcium glycerophosphate (CGP) 10% in an aqueous lotion, applied once daily for 42 days starting at the third postoperative day.
Number of subjects: 20
Study 22240886 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group).
Number of subjects: 20
Study 18847321 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 microg (800 IU) vitamin D supplementation
Number of subjects: 48
Study 18847321 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 microg (400 IU) vitamin D supplementation
Number of subjects: 48
Study 18847321 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 16581474 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantitative adenosine real-time myocardial contrast echocardiography (MCE)
Number of subjects: 43
Study 14675309 — intervention group
Group type: EXPERIMENTAL
Intervention: FACT/GOG-Ntx questionnaire for patients with known neurotoxicities
Number of subjects: 0
Study 14675309 — intervention group
Group type: COMPARATOR
Intervention: FACT/GOG-Ntx questionnaire for chemotherapy-naive women
Number of subjects: 0
Study 10838234 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronze level tuition
Number of subjects: 495
Study 10838234 — intervention group
Group type: COMPARATOR
Intervention: Conventional course
Number of subjects: 495
Study 9330135 — intervention group
Group type: EXPERIMENTAL
Intervention: Computed Tomography (CT)
Number of subjects: 19
Study 9330135 — intervention group
Group type: COMPARATOR
Intervention: Plain Radiography
Number of subjects: 19
Study 9330135 — intervention group
Group type: EXPERIMENTAL
Intervention: Both CT and Plain Radiography
Number of subjects: 19
Study 8471588 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 400 mg
Number of subjects: 68
Study 8471588 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydrocodeine 60 mg
Number of subjects: 68
Study 8471588 — intervention group
Group type: COMPARATOR
Intervention: Dihydrocodeine 30 mg
Number of subjects: 68
Study 3545106 — intervention group
Group type: EXPERIMENTAL
Intervention: Aztreonam and Clindamycin (A/C)
Number of subjects: 84
Study 3545106 — intervention group
Group type: COMPARATOR
Intervention: Gentamicin and Clindamycin (G/C)
Number of subjects: 84
Study 29552916 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent low-dose urokinase (UK) 10,000 U/kg once a day for 7 days
Number of subjects: 48
Study 29552916 — intervention group
Group type: COMPARATOR
Intervention: Alteplase (rt-PA) 50 mg by intravenous injection within 2 hours of admission
Number of subjects: 48
Study 27135252 — intervention group
Group type: EXPERIMENTAL
Intervention: Permissive parenting (lax-inconsistent disciplining) by parents
Number of subjects: 67
Study 27135252 — intervention group
Group type: EXPERIMENTAL
Intervention: Father's unsafe behaviors (modeling)
Number of subjects: 67
Study 24972101 — intervention group
Group type: EXPERIMENTAL
Intervention: Video‐feedback Intervention to promote Positive Parenting and Sensitive Discipline (VIPP‐SD)
Number of subjects: 43
Study 24972101 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 43
Study 22643798 — intervention group
Group type: EXPERIMENTAL
Intervention: Cemented, unconstrained, cruciate‐retaining TKA with a rotating platform (normal group with less than 10° rotational mismatch)
Number of subjects: 80
Study 22643798 — intervention group
Group type: EXPERIMENTAL
Intervention: Cemented, unconstrained, cruciate‐retaining TKA with a rotating platform (group with more than 10° rotational mismatch)
Number of subjects: 80
Study 21110263 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjects with MS (RRMS and SPMS)
Number of subjects: 96
Study 21110263 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjects with RRMS
Number of subjects: 96
Study 21110263 — intervention group
Group type: COMPARATOR
Intervention: Control subjects without MS
Number of subjects: 96
Study 17997100 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexion splinting (70 degrees of flexion over an inactive CPM machine for 24 hours post-operation)
Number of subjects: 95
Study 17997100 — intervention group
Group type: COMPARATOR
Intervention: Extension splinting (full extension for the first 24 hours post-operation)
Number of subjects: 95
Study 16449270 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 week supervised pulmonary rehabilitation (PR) programme
Number of subjects: 100
Study 16449270 — intervention group
Group type: COMPARATOR
Intervention: 7 week supervised pulmonary rehabilitation (PR) programme
Number of subjects: 100
Study 12593590 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided Tissue Regeneration (GTR)
Number of subjects: 9
Study 12593590 — intervention group
Group type: COMPARATOR
Intervention: Open flap debridement (Control)
Number of subjects: 9
Study 10701893 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose intravenous immunoglobulin therapy (IVIG) 2 g/kg bodyweight
Number of subjects: 22
Study 10701893 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 9554161 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene 100 mg/day
Number of subjects: 6
Study 9554161 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene 150 mg/day
Number of subjects: 6
Study 9554161 — intervention group
Group type: EXPERIMENTAL
Intervention: Exogenous oestrogens
Number of subjects: 6
Study 9554161 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene 50 mg/day
Number of subjects: 6
Study 8211584 — intervention group
Group type: EXPERIMENTAL
Intervention: Spontaneous placental detachment, in situ uterine repair
Number of subjects: 100
Study 8211584 — intervention group
Group type: EXPERIMENTAL
Intervention: Spontaneous placental detachment, exteriorized uterine repair
Number of subjects: 100
Study 8211584 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual placental removal, in situ uterine repair
Number of subjects: 100
Study 8211584 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual placental removal, exteriorized uterine repair
Number of subjects: 100
Study 8211584 — intervention group
Group type: COMPARATOR
Intervention: Spontaneous placental detachment (groups 1 and 2)
Number of subjects: 100
Study 8211584 — intervention group
Group type: COMPARATOR
Intervention: Manual placental removal (groups 3 and 4)
Number of subjects: 100
Study 3551011 — intervention group
Group type: EXPERIMENTAL
Intervention: intravenous atropine + inhaled oxitropium bromide
Number of subjects: 24
Study 3551011 — intervention group
Group type: EXPERIMENTAL
Intervention: intravenous atropine alone
Number of subjects: 24
Study 3551011 — intervention group
Group type: EXPERIMENTAL
Intervention: intravenous salbutamol + inhaled salbutamol
Number of subjects: 24
Study 3551011 — intervention group
Group type: EXPERIMENTAL
Intervention: intravenous salbutamol alone
Number of subjects: 24
Study 31046594 — intervention group
Group type: EXPERIMENTAL
Intervention: Keeping a private gratitude journal
Number of subjects: 100
Study 31046594 — intervention group
Group type: EXPERIMENTAL
Intervention: Overtly expressing gratitude to the other
Number of subjects: 100
Study 31046594 — intervention group
Group type: COMPARATOR
Intervention: Perceived wife's expressed gratitude as less sincere
Number of subjects: 100
Study 29928924 — intervention group
Group type: EXPERIMENTAL
Intervention: EDS-FLU (93, 186, or 372 μg)
Number of subjects: 323
Study 29928924 — intervention group
Group type: EXPERIMENTAL
Intervention: EDS-FLU (all doses)
Number of subjects: 323
Study 29928924 — intervention group
Group type: COMPARATOR
Intervention: EDS-placebo
Number of subjects: 323
Study 28160585 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical TGO gel
Number of subjects: 180
Study 28160585 — intervention group
Group type: COMPARATOR
Intervention: Triamcinolone acetonide pomade
Number of subjects: 180
Study 28160585 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study 26492839 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic ablative radiotherapy (SABR)
Number of subjects: 22
Study 26492839 — intervention group
Group type: COMPARATOR
Intervention: Surgical resection
Number of subjects: 22
Study 23848078 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training (S; n = 24)
Number of subjects: 96
Study 23848078 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance training (E; n = 26)
Number of subjects: 96
Study 23848078 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined strength and endurance training (SE; n = 24)
Number of subjects: 96
Study 23848078 — intervention group
Group type: EXPERIMENTAL
Intervention: Recommendations of physical activity (PA; n = 22)
Number of subjects: 96
Study 21730344 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based educational modules for vision education
Number of subjects: 107
Study 21730344 — intervention group
Group type: COMPARATOR
Intervention: Control group (chlamydia and blood pressure education)
Number of subjects: 107
Study 19700198 — intervention group
Group type: EXPERIMENTAL
Intervention: Cataract surgery in eyes without AMD
Number of subjects: 4757
Study 19700198 — intervention group
Group type: EXPERIMENTAL
Intervention: Cataract surgery in eyes with mild AMD
Number of subjects: 4757
Study 19700198 — intervention group
Group type: EXPERIMENTAL
Intervention: Cataract surgery in eyes with moderate AMD
Number of subjects: 4757
Study 19700198 — intervention group
Group type: EXPERIMENTAL
Intervention: Cataract surgery in eyes with advanced AMD
Number of subjects: 4757
Study 17123987 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 Necator americanus larvae
Number of subjects: 10
Study 17123987 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 Necator americanus larvae
Number of subjects: 10
Study 17123987 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 Necator americanus larvae
Number of subjects: 10
Study 17123987 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 Necator americanus larvae
Number of subjects: 10
Study 17123987 — intervention group
Group type: EXPERIMENTAL
Intervention: All doses
Number of subjects: 10
Study 15337214 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart failure with preserved EF
Number of subjects: 988
Study 15337214 — intervention group
Group type: EXPERIMENTAL
Intervention: Glomerular filtration rate
Number of subjects: 988
Study 15337214 — intervention group
Group type: EXPERIMENTAL
Intervention: New York Heart Association functional class III or IV
Number of subjects: 988
Study 15337214 — intervention group
Group type: EXPERIMENTAL
Intervention: Male gender
Number of subjects: 988
Study 15337214 — intervention group
Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 988
Study 11235780 — intervention group
Group type: EXPERIMENTAL
Intervention: Forceful saline injections (20 ml) with or without prednisolone acetate (125 mg)
Number of subjects: 47
Study 11235780 — intervention group
Group type: COMPARATOR
Intervention: Epidural prednisolone acetate (125 mg) alone
Number of subjects: 47
Study 9286184 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine (up to 20 mg/day, median exposure 237 days)
Number of subjects: 904
Study 9286184 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol (up to 20 mg/day, median exposure 203 days)
Number of subjects: 904
Study 8420315 — intervention group
Group type: EXPERIMENTAL
Intervention: PROEF diet
Number of subjects: 118
Study 8420315 — intervention group
Group type: COMPARATOR
Intervention: Routine postoperative dietary management (control)
Number of subjects: 118
Study 3764810 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous heparin (5000iu two hours before operation and then twelve hourly for seven days)
Number of subjects: 61
Study 3764810 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous saline (control group)
Number of subjects: 61
Study 28368953 — intervention group
Group type: EXPERIMENTAL
Intervention: Proprioceptive-coordinative training (P-CT; n = 26)
Number of subjects: 53
Study 28368953 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular training (RT; n = 27)
Number of subjects: 53
Study 28368953 — intervention group
Group type: COMPARATOR
Intervention: Control group (C; n = 22)
Number of subjects: 53
Study 28585761 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatic experiencing (SE) therapy, 15 weekly sessions.
Number of subjects: 63
Study 28585761 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group, no intervention during the initial 15 weeks.
Number of subjects: 63
Study 25575716 — intervention group
Group type: EXPERIMENTAL
Intervention: GlideScope® (GS)
Number of subjects: 72
Study 25575716 — intervention group
Group type: EXPERIMENTAL
Intervention: McGrath® Series 5 (McG)
Number of subjects: 72
Study 25575716 — intervention group
Group type: COMPARATOR
Intervention: Direct Laryngoscopy (DL)
Number of subjects: 72
Study 23458112 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative psychodynamic inpatient therapy
Number of subjects: 47
Study 21975307 — intervention group
Group type: COMPARATOR
Intervention: As-finished (600 grit SiC; control)
Number of subjects: 135
Study 21975307 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandblasted
Number of subjects: 135
Study 21975307 — intervention group
Group type: EXPERIMENTAL
Intervention: Etched
Number of subjects: 135
Study 19448968 — intervention group
Group type: EXPERIMENTAL
Intervention: Indigocarmine chromocolonoscopy (Group A)
Number of subjects: 400
Study 19448968 — intervention group
Group type: COMPARATOR
Intervention: Conventional colonoscopy (Group B-1)
Number of subjects: 400
Study 19448968 — intervention group
Group type: EXPERIMENTAL
Intervention: Chromocolonoscopy (Group B-2)
Number of subjects: 400
Study 19448968 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced lesions (all groups)
Number of subjects: 400
Study 19448968 — intervention group
Group type: EXPERIMENTAL
Intervention: Diminutive polyps (Groups A and B-2)
Number of subjects: 400
Study 16496492 — intervention group
Group type: EXPERIMENTAL
Intervention: EDTA (35 mg/kg)
Number of subjects: 8
Study 16496492 — intervention group
Group type: EXPERIMENTAL
Intervention: EDTA + AC (50 grams)
Number of subjects: 8
Study 16496492 — intervention group
Group type: COMPARATOR
Intervention: Control (water)
Number of subjects: 8
Study 14671696 — intervention group
Group type: EXPERIMENTAL
Intervention: Saphenofemoral disconnection under local anesthesia
Number of subjects: 84
Study 14671696 — intervention group
Group type: COMPARATOR
Intervention: Enoxaparin on an outpatient basis for 4 weeks
Number of subjects: 84
Study 11187915 — intervention group
Group type: EXPERIMENTAL
Intervention: DCLSG protocol ALL-6 (1984-1988) with chemotherapeutic CNS prophylaxis (dexamethasone, i.v. medium dose methotrexate, intrathecal triple therapy) for 116 weeks
Number of subjects: 408
Study 11187915 — intervention group
Group type: EXPERIMENTAL
Intervention: DCLSG protocol ALL-7 (identical to ALL-BFM-86 protocol, cranial irradiation restricted to patients with initial CNS involvement) for 18 months
Number of subjects: 408
Study 11187915 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard risk non-T lineage ALL patients in protocol ALL-6
Number of subjects: 408
Study 11187915 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard risk non-T lineage ALL patients in protocol ALL-7
Number of subjects: 408
Study 8646873 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate ointment, 0.005%
Number of subjects: 372
Study 8646873 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 372
Study 1995934 — intervention group
Group type: EXPERIMENTAL
Intervention: Proguanil 100 mg daily
Number of subjects: 76
Study 1995934 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorproguanil 20 mg twice weekly
Number of subjects: 76
Study 1995934 — intervention group
Group type: COMPARATOR
Intervention: Placebo prophylaxis
Number of subjects: 76
Study 6548940 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucralfate (5 g given in 1-g divided doses)
Number of subjects: 9
Study 6548940 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen (600 mg)
Number of subjects: 9
Study 30073637 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone (XR-NTX)
Number of subjects: 51
Study 29912571 — intervention group
Group type: EXPERIMENTAL
Intervention: PAT+ (Parents as Teachers with additional content on breastfeeding)
Number of subjects: 118
Study 29912571 — intervention group
Group type: COMPARATOR
Intervention: PAT (Parents as Teachers)
Number of subjects: 118
Study 29912571 — intervention group
Group type: EXPERIMENTAL
Intervention: PAT+
Number of subjects: 118
Study 29912571 — intervention group
Group type: COMPARATOR
Intervention: PAT
Number of subjects: 118
Study 26314868 — intervention group
Group type: EXPERIMENTAL
Intervention: SOS prevention program
Number of subjects: 0
Study 26314868 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 24656947 — intervention group
Group type: EXPERIMENTAL
Intervention: Rare hamburger
Number of subjects: 1046
Study 24656947 — intervention group
Group type: COMPARATOR
Intervention: Well-done hamburger
Number of subjects: 1046
Study 24656947 — intervention group
Group type: EXPERIMENTAL
Intervention: All hamburgers (rare, medium rare, medium well-done, well-done)
Number of subjects: 1046
Study 24656947 — intervention group
Group type: EXPERIMENTAL
Intervention: Rare hamburgers
Number of subjects: 1046
Study 22201688 — intervention group
Group type: EXPERIMENTAL
Intervention: Clay pitch surface
Number of subjects: 22